Literature DB >> 16006335

The effect of a bacteriophage on diversification of the opportunistic bacterial pathogen, Pseudomonas aeruginosa.

Michael A Brockhurst1, Angus Buckling, Paul B Rainey.   

Abstract

Pseudomonas aeruginosa is an opportunistic human pathogen that colonizes the lungs of cystic fibrosis (CF) patients. CF lungs often contain a diverse range of P. aeruginosa phenotypes, some of which are likely to contribute to the persistence of infection, yet the causes of diversity are unclear. While the ecological heterogeneity of the lung environment and therapeutic regimes are probable factors, a role for parasitic bacteriophage cannot be ruled out. Parasites have been implicated as a key ecological variable driving the evolution of diversity in host populations. PP7 drove cycles of morphological diversification in host populations of P. aeruginosa due to the de novo evolution of small-rough colony variants that coexisted with large diffuse colony morph bacteria. In the absence of phage, bacteria only displayed the large diffuse colony morphology of the wild-type. Further assays revealed there to be two distinct types of resistant bacteria; these had very different ecological phenotypes, yet each carried a cost of resistance.

Entities:  

Mesh:

Year:  2005        PMID: 16006335      PMCID: PMC1560335          DOI: 10.1098/rspb.2005.3086

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  39 in total

Review 1.  Molecular switches--the ON and OFF of bacterial phase variation.

Authors:  I R Henderson; P Owen; J P Nataro
Journal:  Mol Microbiol       Date:  1999-09       Impact factor: 3.501

2.  Maintenance of genetic variation in phenotypic plasticity: the role of environmental variation.

Authors:  G de Jong; S Gavrilets
Journal:  Genet Res       Date:  2000-12       Impact factor: 1.588

3.  Host-parasite coevolution in a multilocus gene-for-gene system.

Authors:  A Sasaki
Journal:  Proc Biol Sci       Date:  2000-11-07       Impact factor: 5.349

Review 4.  Phenotypic plasticity in the interactions and evolution of species.

Authors:  A A Agrawal
Journal:  Science       Date:  2001-10-12       Impact factor: 47.728

Review 5.  Mechanisms of antibiotic resistance in bacterial biofilms.

Authors:  Philip S Stewart
Journal:  Int J Med Microbiol       Date:  2002-07       Impact factor: 3.473

6.  Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities.

Authors:  E Déziel; Y Comeau; R Villemur
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

7.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

Authors:  A Oliver; R Cantón; P Campo; F Baquero; J Blázquez
Journal:  Science       Date:  2000-05-19       Impact factor: 47.728

8.  Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation.

Authors:  Eliana Drenkard; Frederick M Ausubel
Journal:  Nature       Date:  2002-04-18       Impact factor: 49.962

Review 9.  Cystic fibrosis.

Authors:  Amanda L Brennan; Duncan M Geddes
Journal:  Curr Opin Infect Dis       Date:  2002-04       Impact factor: 4.915

Review 10.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

View more
  58 in total

1.  An experimental study of the population and evolutionary dynamics of Vibrio cholerae O1 and the bacteriophage JSF4.

Authors:  Yan Wei; Paolo Ocampo; Bruce R Levin
Journal:  Proc Biol Sci       Date:  2010-06-10       Impact factor: 5.349

2.  The costs of evolving resistance in heterogeneous parasite environments.

Authors:  Britt Koskella; Derek M Lin; Angus Buckling; John N Thompson
Journal:  Proc Biol Sci       Date:  2011-12-14       Impact factor: 5.349

3.  Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.

Authors:  Joanne L Fothergill; Eilidh Mowat; Martin J Walshaw; Martin J Ledson; Chloe E James; Craig Winstanley
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

4.  Using experimental evolution to explore natural patterns between bacterial motility and resistance to bacteriophages.

Authors:  Britt Koskella; Tiffany B Taylor; Jennifer Bates; Angus Buckling
Journal:  ISME J       Date:  2011-04-21       Impact factor: 10.302

5.  Coevolving parasites enhance the diversity-decreasing effect of dispersal.

Authors:  Tom Vogwill; Andy Fenton; Michael A Brockhurst
Journal:  Biol Lett       Date:  2011-02-16       Impact factor: 3.703

Review 6.  Trade-offs between competition and defense specialists among unicellular planktonic organisms: the "killing the winner" hypothesis revisited.

Authors:  Christian Winter; Thierry Bouvier; Markus G Weinbauer; T Frede Thingstad
Journal:  Microbiol Mol Biol Rev       Date:  2010-03       Impact factor: 11.056

7.  Coral Mucus Is a Hot Spot for Viral Infections.

Authors:  Hanh Nguyen-Kim; Yvan Bettarel; Thierry Bouvier; Corinne Bouvier; Hai Doan-Nhu; Lam Nguyen-Ngoc; Thuy Nguyen-Thanh; Huy Tran-Quang; Justine Brune
Journal:  Appl Environ Microbiol       Date:  2015-06-19       Impact factor: 4.792

8.  Predation in homogeneous and heterogeneous phage environments affects virulence determinants of Pseudomonas aeruginosa.

Authors:  Zeinab Hosseinidoust; Nathalie Tufenkji; Theo G M van de Ven
Journal:  Appl Environ Microbiol       Date:  2013-02-22       Impact factor: 4.792

9.  Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions.

Authors:  Alana Schick; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

10.  CRISPR associated diversity within a population of Sulfolobus islandicus.

Authors:  Nicole L Held; Alfa Herrera; Hinsby Cadillo-Quiroz; Rachel J Whitaker
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.